Hello, everyone, and thank you for joining us to discuss Gentherm and Modine's announcement of our plans for a spin-off and ...
Kura Oncology holds a strong cash position with Komzifti FDA approval and frontline AML expansion potential. Read why KURA ...
8d
Matchbook AI's Anusha Nara Takes Center Stage at ng-India as Speaker, Panelist, and Startup Mentor
Matchbook AI's Client Success Manager Anusha Nara, being both speaker and panelist, effectively positioned Matchbook AI as a ...
Atea showcased its Phase III HCV programme at JPM for bemnifosbuvir/ruzasvir, positioning the regimen for test-and-treat ...
Century Communities, Inc. (NYSE:CCS) Q4 2025 Earnings Call Transcript January 28, 2026 Century Communities, Inc. misses on ...
All things considered, John Ternus is the center of speculation as being the best and most likely choice for control of the ...
HALIFAX, NS / ACCESS Newswire /3, 2026 / Silver Tiger Metals Inc. (TSXV:SLVR) and (OTCQX:SLVTF) ("Silver Tiger" or the "Corporation") is ...
Forensic audit using advanced AI reveals the objective logic of the soul, offering a user manual for consciousness ...
Media Release Entered into strategic collaboration with Dr. Reddy's for commercialisation of eftilagimod alfa (efti) in all countries outside North America, Europe, Japan, and Greater ChinaIn January ...
Executives reiterated the target securities-to-assets ratio in the 12%-15% range, with $25 million in securities maturities ...
DENVER, CO / ACCESS Newswire / January 20, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central n ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results